Immunological hiding of herpesvirus-infected cells

Archives of Virology

Volumn 145, Issue 7, 2000, Pages 1269-1290

  Favoreel, H W ^b   Nauwynck, H J ^a   Pensaert, M B ^b  

^a GHENT UNIVERSITY   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANTIGENIC MODULATION; CYTOTOXICITY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; IMMUNOLOGY; PHAGOCYTOSIS; RAT; REVIEW; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

ANIMALS; ANTIGENIC MODULATION; CYTOTOXICITY, IMMUNOLOGIC; HERPES SIMPLEX; PHAGOCYTOSIS; RATS; SIMPLEXVIRUS; T-LYMPHOCYTE SUBSETS;

EID: 0033658028     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050070090     Document Type: Short Survey

References (101)

1. Ahn K, Angelo A, Ghazal P, Peterson PA, Yang Y, Früh K (1996) Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci USA 93: 10 990-10 995
2. Ahn K, Gruhler A, Galocha B, Jones TR, Wiertz EJHJ, Ploegh HL, Peterson PA, Yang Y, Früh K (1997) The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6: 613-621
3. Albrecht JC, Fleckenstein B (1992) New member of the multigene family of complement control proteins in herpesvirus saimiri. J Virol 66: 5 047-5 048
4. Albrecht JC, Nicholas J, Cameron R, Newman C, Fleckenstein B, Honess RW (1992) Herpesvirus saimiri has a gene specifying a homologue of the cellular membrane glycoprotein CD59. Virology 190: 527-530
5. Beck S, Barrell BG (1988) Human cytomegalovirus encodes a glycoprotein homologues to MHC class-I antigens. Nature 331: 269-272
6. Berthomme H, Jacquemont B, Epstein A (1993) The pseudorabies virus host-shutoff homolog gene: nucleotide sequence and comparison with alphaherpesvirus protein counterparts. Virology 193: 1 028-1 032
7. Björkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329: 506-512
8. Bodaghi B, Jones RT, Zipeto D, Vita C, Sun L, Laurent L, Arenzana-Seisdedos F, Virelizier JL, Michelson S (1998) Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells. J Exp Med 188: 855-866
9. Borysiewicz LK, Hickling JK, Graham S, Sinclair J, Cranage MP, Smith GL, and Sissons JGP (1988) Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognising the 72-kDa immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J Exp Med 168: 919-931
10. Browne H, Smith G, Beck S, Minson T (1990) A complex between the MHC class I homologue encoded by human cytomegalovirus and β2 microglobulin. Nature 347: 770-772
11. Brutkiewicz RR, Welsh RM (1995) Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells. J Virol 69: 3 967-3 971
12. Burchett SK, Corey L, Mohan KM, Westall J, Ashley R, Wilson CB (1992) Diminished interferon-g and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J Infect Dis 165: 813-818
13. Chapman TL, Björkman PJ (1998) Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. J Virol 72: 460-467
14. Confer DL, Vercellotti GM, Kotasek D, Goodman JL, Ochoa A, Jacobs HS (1990) Herpes simplex virus-infected cells disarm killer lymphocytes. Proc Natl Acad Sci USA 87: 3 609-3 613
15. Cunningham AL, Merigan TC (1983) Gamma interferon production appears to predict time of recurrence of herpes labialis. J Immunol 130: 2 397-2 400
16. de Jong MD, Galasso GJ, Gazzard B, Griffiths PD, Jabs DA, Kern ER, Spector SA (1998) Summary of the II International Symposium on Cytomegalovirus. Antiviral Res 39: 141-162
17. Dowler KW, Veltri RW (1984) In vitro neutralization of HSV-2; Inhibition by binding of normal IgG and purified Fc to virion Fc receptor (FcR). J Med Virol 13: 251-259
18. Drew PD, Lonergan M, Goldstein ME, Lampson LA, Ozato K, McFarlin DE (1993) Regulation of MHC class I and beta 2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes. J Immunol 150: 3 300-3 310
19. Fahnestock ML, Johnson JL, Feldman RMR, Neveu JM, Lane WS, Björkman PJ (1995) The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3: 583-590
20. Farrell HE, Vally H, Lynch DM, Fleming P, Shellam GR, Scalzo AA, Davis-Poynter NJ (1997) Inhibition of natural killer cells by a cytomegalovirus class I homologue in vivo. Nature 386: 510-514
21. Favoreel H (1999) Antibody-induced clearance of viral and cellular plasma membrane proteins from pseudorabies virus-infected cells, and its possible role in viral immune evasion. PhD thesis, University of Gent, Belgium
22. Favoreel HW, Nauwynck HJ, Halewyck HM, Van Oostveldt P, Mettenleiter TC, Pensaert MB (1999a) Antibody-induced endocytosis of viral glycoproteins and major histocompatibility complex class I on pseudorabies virus-infected monocytes. J Gen Virol 80: 1 283-1 291
23. Favoreel HW, Nauwynck HJ, Pensaert MB (1999b) Role of the cytoplasmic tail of gE during antibody-induced redistribution of viral glycoproteins, expressed on pseudorabies virus-infected cells. Virology 259: 141-147
24. Favoreel HW, Nauwynck HJ, Van Oostveldt P, Mettenleiter TC, Pensaert MB (1997) Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells. J Virol 71: 8254-8261
25. Feng X, Thompson YG, Lewis JB, Caughman GB (1996) Expression and function of the equine herpesvirus 1 virion-associated host shutoff homolog. J Virol 70: 8 710-8 718
26. Fitzgerald-Bocarsly P, Feldman M, Curl S, Schnell J, Denny T (1989) Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji. J Immunol 143: 1 318-1 326
27. Fodor WL, Rollins SA, Bianco-Caron S, Rother RP, Guilmette ER, Burton WV, Albrecht JC, Fleckenstein B, Squinto SP (1995) The complement control protein homolog of herpesvirus saimiri regulates serum complement by inhibiting C3 convertase activity. J Virol 69: 3 389-3 392
28. Frank I, Friedman HM (1989) A novel function for the herpes simplex virus type I Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J Virol 63: 4 479-4 488
29. Friedman HM, Cohen GH, Eisenberg RJ, Seidel CA, Cines DB (1984) Glycoprotein C of herpes simplex virus I acts as a receptor for the C3b complement component on infected cells. Nature 309: 633-635
30. Früh K, Ahn K, Djaballah H, Sempe P, van Endert PM, Tampe R, Peterson PA, Yang Y (1995) A viral inhibitor of peptide transporters for antigen presentation. Nature 375: 415-418
31. Fujita T, Inoue T, Ogawa K, Iida K, Tamura N (1987) The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 by dissociating C2a and Bb. J Exp Med 166: 1 221-1 228
32. Gilbert MJ, Riddell SR, Plachter B, Greenberg PD (1996) Cytomegalovirus selectivity blocks antigen processing and presentation of its immediate-early gene product. Nature 383: 720-722
33. Guidotti LG, Ando K, Hobbs MV, Ishikawa T, Runkel L, Schreiber RD, Chisari FV (1994) Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a non-cytolytic mechanism in transgenic mice. Proc Natl Acad Sci USA 91: 3 764-3 768
34. Hanon E, Keil G, van Drunen Little-van den Hurk S, Griebel P, Vanderplasschen A, Rijsewijk FAM, Babiuk L, Pastoret PP (1999) Bovine herpesvirus 1-induced apoptotic cell death: role of glycoprotein D. Virology 257: 191-197
35. Hanon E, Lambot M, Hoornaert S, Lyaku J, Pastoret PP (1998a) Bovine herpesvirus 1-induced apoptosis: phenotypic characterization of susceptible peripheral blood mononuclear cells. Arch Virol 143: 441-452
36. Hanon E, Meyer G, Vanderplasschen A, DessyDoize C, Thiry E, Pastoret PP (1998b) Attachment but not penetration of bovine herpesvirus 1 is necessary to induce apoptosis in target cells. J Virol 72: 7 638-7 641
37. Hanon E, Vanderplasschen A, Keil G, Denis M, Pastoret PP (1996) Inactivated bovine herpesvirus 1 induces apoptotic cell death of mitogen-stimulated bovine peripheral blood mononuclear cells. J Virol 70: 4 116-4 120
38. Heemels MT, Ploegh HL (1995) Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem 64: 463-491
39. Hill AB, Barnett BC, McMichael AJ, McGeoch DJ (1994) HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J Immunol 152: 2 736-2 741
40. Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D (1995) Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411-415
41. Hirsch RL (1982) The complement system: its importance in the host response to viral infection. Microbiol Rev 46: 71-85
42. Hsu DH, De Waal-Malefyt R, Fiorentino DF, Dang MN, Vieira P, de Vries J, Spits H, Mosmann TR, Moore KW (1990) Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250: 830-832
43. Huemer HP, Larcher C, Coe NE (1992) Pseudorabies virus glycoprotein III derived from virions and infected cells binds to the third component of complement. Virus Res 23: 271-280
44. Huemer HP, Larcher C, van Drunen Littel-van den Hurk S, Babuik LA (1993) Species selective interaction of alphaherpesvirinae with the "unspecific" immune system of the host. Arch Virol 130: 353-364
45. Huemer HP, Nowotny N, Crabb BS, Meyer H, Hubert PH (1995) gp13 (EHV-gC): a complement receptor induced by equine herpesviruses. Virus Res 37: 113-126
46. Ilobi CP, Martin BA (1990) Macromolecular synthesis in varicella-zoster virus-infected epithelial and fibroblast cells. J Gen Virol 71: 949-952
47. Jiang Y, Hossain A, Winkler MT, Holt T, Doster A, Jones C (1998) A protein encoded by the latency-related gene of bovine herpesvirus 1 is expressed in trigeminal ganglionic neurons of latently infected cattle and interacts with cyclin-dependent kinase 2 during productive infection. J Virol 72: 8 133-8 142
48. Johnson DC, Hill AB (1998) Herpesvirus evasion of the immune system. Curr Top Microbiol Immunol 232: 149-177
49. Johnson DC, Frame MC, Ligas MW, Cross AM, Stow ND (1988) Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J Virol 62: 1 347-1 354
50. Jones TR, Wiertz EJHJ, Sun L, Fish KN, Nelson JA, Ploegh HL (1996) Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci USA 93: 11 327-11 333
51. Jones C (1998) Alphaherpesvirus latency: its role in disease and survival of the virus in nature. Adv Virus Res 51: 81-133
52. Kägi D, Vignaux F, Lederman B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P (1994) Fas perforin pathways as major mechanisms of cell-mediated cytotoxicity. Science 265: 528-530
53. Kärre K (1995) Express yourself or die: peptides, MHC molecules, and NK cells. Science 267: 978-979
54. Kärre K, Welsh RM (1997) Viral decoy vetoes killer cell. Nature 386: 446-447
55. Kimman TG, Bianchi AT, de Bruin TG, Mulder WA, Priem J, Voermans JJ (1995) Interaction of pseudorabies virus with immortalized porcine B cells: influence on surface class I and II major histocompatibility complex and immunoglobulin M expression. Vet Immunol Immunopathol 45: 253-263
56. Kleinjen MF, Huppa JB, Lucin P, Mukherjee S, Farrell H, Campbell AE, Koszinowski UH, Hill AB, Ploegh HL (1997) A mouse cytomegalovirus protein, gp 34 forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. EMBO J 16: 685-694
57. Kwong AD, Kruper JA, Frenkel N (1988) Herpes simplex virus virion host shutoff function. J Virol 62: 912-921
58. Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci MG (1997) Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen I. Proc Natl Acad Sci USA 94: 12 616-12 621
59. Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Müllen PM, Klein G, Kurilla MG, Masucci MG (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-I. Nature 375: 685-688
60. Litwin V, Jackson W, Grose C (1992) Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J Virol 66: 3 643-3 651
61. Lowing B, Hahne M, Mattmann C, Tschopp J (1994) Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370: 650-652
62. Lubinski JM, Wang L, Soulika AM, Burger R, Wetsel RA, Colten H, Cohen GH, Eisenberg RJ, Lambris JD, Friedman HM (1998) Herpes simplex virus type 1 glycoprotein gC mediates immune evasion in vivo. J Virol 72: 8 257-8 263
63. Machold RP, Wiertz EJHJ, Jones RT, Ploegh HL (1997) The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. J Exp Med 185: 363-366
64. McCulloch J, Williamson SA, Powis SJ, Edington N (1993) The effect of EHV-1 infection upon circulating leucocyte populations in the natural equine host. Vet Microbiol 37: 147-161
65. Mellencamp MW, O'Brien PC, Stevenson JR (1991) Pseudorabies virus-induced suppression of major histocompatibility complex class I antigen expression. J Virol 65: 3 365-3 368
66. Mikloska Z, Kesson AM, Penfold ME, Cunningham AL (1996) Herpes simplex virus protein targets for CD4 and CD8 lymphocyte cytotoxicity in cultured epidermal keratinocytes treated with interferon-gamma. J Infect Dis 173: 7-17
67. Mold C, Bradt BM, Nemerow GR, Cooper NR (1988) Epstein-Barr virus regulates activation and processing of the third component of complement. J Exp Med 168: 949-969
68. Moore KW, O'Garra A, De Waal-Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11: 165-190
69. Mulder WA, Priem J, Pol JM, Kimman TG (1995) Role of viral proteins and concanavalin A in in vitro replication of pseudorabies virus in porcine peripheral blood mononuclear cells. J Gen Virol 76: 1 433-1 442
70. Nossal GJ (1994) Negative selection of lymphocytes. Cell 76: 229-239
71. Plemper RK, Bohmler S, Bordallo J, Sommer T, Wolf DH (1997) Mutant analysis links the translocon and bip to retrograde protein transport for ER degradation. Nature 388: 891-895
72. Posavad CM, Newton JJ, Rosenthal KL (1994) Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus. J Virol 68: 4 072-4 074
73. Raftery MJ, Behrens CK, Muller A, Krammer PH, Walczak H, Schonrich G (1999) Herpes simplex virus type 1 infection of activated cytotoxic T cells. Induction of fratricide as a mechanism of viral immune evasion. J Exp Med 190: 1 103-1 114
74. Rammensee HG, Falk K, Rotzschke O (1993) Peptides naturally presented by MHC class I molecules. Ann Rev Immunol 11: 213-244
75. Raulet DH (1996) Recognition events that inhibit and activate natural killer cells. Curr Opin Immunol 8: 372-377
76. Rawlinson WD, Farrell HE, Barrell BG (1996) Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70: 8 833-8 849
77. Reyburn HT, Mandelboim O, Vales-Gomez M, Davis DM, Pazmany L, Strominger JL (1997) The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386: 514-517
78. Roitt I, Brostoff J, Male D (1993) Immunology. Mosby, London
79. Rother RP, Rollins SA, Fodor WL, Albrecht JC, Setter E, Fleckenstein B, Squinto SP (1994) Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J Virol 68: 730-737
80. Rother K, Till GO (1988) The complement system. Springer, Berlin Heidelberg New York Tokyo
81. Schang LM, Hossain A, Jones C (1996) The latency-related gene of bovine herpesvirus 1 encodes a product which inhibits cell cycle progression. J Virol 70: 3 807-3 814
82. Schmidt CW, Misko IS (1995) The ecology and pathology of Epstein-Barr virus. Immunol Cell Biol 73: 489-504
83. Sparks-Thissen RL, Enquist LW (1999) Differential regulation of Dk and Kk major histocompatibility complex class I proteins on the cell surface after infection of murine cells by pseudorabies virus. J Virol 73: 5 748-5 756
84. Telford EAR, Watson MW, Aird HA, Perry J, Davison AJ (1994) The DNA sequence of equine herpesvirus 2. J Mol Biol 249: 520-528
85. Thäle T, Lucin P, Schneider K, Eggers M, Koszinowski U (1994) Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J Virol 68: 7 757-7 765
86. Thäle R, Szepan U, Hengel H, Geginat G, Lucin P, Koszinowski UH (1995) Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport. J Virol 69: 6 098-6 105
87. Thandavarayan N, Lubinski J, Wang L, Goldstein LT, Weeks BS, Sundaresan P, Kang EH, Dubin G, Friedman HM (1998) In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J Virol 72: 5 351-5 359
88. Tigges MA, Koelle D, Hartog K, Sekulovich RE, Corey L, Burke RL (1992) Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens. J Virol 66: 1 622-1 634
89. Tigges MA, Leng S, Johnson DC, Burke RL (1996) Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled. J Immunol 156: 3 901-3 910
90. Tomazin R, Hill AB, Jugovic P, York I, van Endert P, Ploegh HL, Andrews DW, Johnson DC (1996). Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J 15: 3 256-3 266
91. Vieira P, De Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, de Vries JE, Roncarolo MG, Mosmann TR, Moore KW (1991) Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 88: 1 172-1 176
92. th, Latreille P, Wamsley P, Hallsworth K, Week KE, Dal Canto AJ, Speck SH (1997) Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71: 5 894-5 904
93. Wattre P, Dewilde A, Lobert PE (1995) Current status of human cytomegalovirus disease. Rev Med Int 16: 354-367
94. Wiertz EJHJ, Jones RT, Sun L, Bogyo M, Geuze HJ, Ploegh HL (1996) The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmatic reticulum to the cytosol. Cell 84: 769-779
95. Wiertz EJHJ, Tortorella D, Bogyo M, Yu J, Mothes W, Jones TR, Rapoport TA, Ploegh HL (1996) Sec61-mediated transfer of a membrane protein from the endoplasmatic reticulum to the proteasome for destruction. Nature 384: 432-438
96. Wittmann G, Ohlinger V, Rziha HJ (1983) Occurrence and reactivation of latent Aujeszky's disease virus following challenge in previously vaccinated pigs. Arch Virol 75: 29-41
97. Yamamoto T, Osaki T, Yoneda K, Ueta E (1993) Immunological investigation of adult patients with primary herpes simplex virus-1 infection. J Oral Pathol Med 22: 263-267
98. York IA (1996) Immune evasion strategies of the herpesviruses. Chem Biol 3: 331-335
99. York IA, Johnson DC (1993) Direct contact with herpes simplex virus-infected cells results in inhibition of lymphokine-activated killer cells because of cell-to-cell spread of virus. J Infect Dis 168: 1 127-1 132
100. York IA, Roop C, Andrews DW, Riddell SR, Graham FL, Johnson DC (1994) A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77: 525-535
101. Ziegler H, Thale R, Lucin P, Muranyi W, Flohr T, Hengel H, Farrell H, Rawlinson W, Koszinowski UH (1997) A mouse cytomegalovirus protein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6: 57-66